Stay updated on Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent change in the webpage content.
    Difference
    0.1%
    Check dated 2024-06-13T22:49:43.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the overall response rate (ORR) assessment by nivolumab and metformin combination in treating patients with microsatellite stable (MSS) stage IV colorectal cancer that has not responded to previous treatment.
    Difference
    0.1%
    Check dated 2024-06-06T14:51:07.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change provides a more detailed explanation of eligibility criteria, including examples such as a person's general health condition or prior treatments.
    Difference
    49%
    Check dated 2024-05-22T21:38:04.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:34:58.000Z thumbnail image

Stay in the know with updates to Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Metformin in MSS Colorectal Cancer Clinical Trial page.